Fresenius Medical Care (NYSE: FMS), the world’s largest provider of dialysis products and services, announced today its introduction of the WetAlert wireless wetness detector, designed to detect venous needle displacement and prevent blood loss for dialysis patients at home. The WetAlert transmitter is the only device in the U.S. market that senses moisture at the venous needle site and sets off a process to automatically stop the blood pump, close the venous clamp, display a visual alarm, and sound an audible alarm. The device transmits radio signals directly to the 2008K@home machine. It is unique and highly effective in design, and reusable for up to six months.
Venous needle dislodgement (VND) is a potential, serious complication related to dialysis therapy. If the venous needle becomes dislodged or disconnected from the patient’s vascular access, it could cause the patient to hemmorhage.
“The WetAlert wireless wetness detector is a brand new option that may help reduce the fear of blood leaks during home dialysis because the blood pump stops on the 2008K@home machine, thereby decreasing the amount of potential blood loss if VND occurs,” said Dr. Jose Diaz-Buxo, MD, FACP, Chief Medical Officer at Fresenius Medical Care. Recently, the U.S. Food and Drug Administration (FDA) cleared the WetAlert wireless wetness detector for use.
About Fresenius Medical Care North AmericaThrough our leading network of more than 2,100 dialysis facilities in North America and our vascular access centers, laboratory, pharmacy and affiliated hospitals and nephrology practices, Fresenius Medical Care provides renal services to hundreds of thousands of people throughout the United States, Mexico and Canada. We are also the continent's top producer of dialysis equipment, dialyzers and related disposable products and a major supplier of renal pharmaceuticals. For more information about the company, visit www.fmcna.com; for information about patient services, visit www.ultracare-dialysis.com Legal Disclaimer:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts